These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1104 related articles for article (PubMed ID: 34481967)

  • 21. SARS-CoV-2 anti-spike antibody titres after vaccination with BNT162b2 in naïve and previously infected individuals.
    Lombardi A; Consonni D; Oggioni M; Bono P; Uceda Renteria S; Piatti A; Pesatori AC; Castaldi S; Muscatello A; Riboldi L; Ceriotti F; Bandera A; Gori A
    J Infect Public Health; 2021 Aug; 14(8):1120-1122. PubMed ID: 34293641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare Workers.
    Marot S; Malet I; Leducq V; Abdi B; Teyssou E; Soulie C; Wirden M; Rodriguez C; Fourati S; Pawlotsky JM; Boutolleau D; Burrel S; Calvez V; Marcelin AG; Jary A
    Clin Infect Dis; 2022 Mar; 74(4):707-710. PubMed ID: 34050731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].
    Topkaya AE; Keskin AÜ; Dalan AB; Çıragil P
    Mikrobiyol Bul; 2022 Jan; 56(1):139-142. PubMed ID: 35088968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics of healthcare workers with SARS-CoV-2 infection after vaccination with BNT162b2 vaccine.
    Lombardi A; Renisi G; Consonni D; Oggioni M; Bono P; Uceda Renteria S; Piatti A; Pesatori AC; Castaldi S; Muscatello A; Riboldi L; Ceriotti F; Gori A; Bandera A
    BMC Infect Dis; 2022 Jan; 22(1):97. PubMed ID: 35090388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Live virus neutralization testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2.
    Saade C; Gonzalez C; Bal A; Valette M; Saker K; Lina B; Josset L; Trabaud MA; Thiery G; Botelho-Nevers E; Paul S; Verhoeven P; Bourlet T; Pillet S; Morfin F; Trouillet-Assant S; Pozzetto B; On Behalf Of Covid-Ser Study Group
    Emerg Microbes Infect; 2021 Dec; 10(1):1499-1502. PubMed ID: 34176436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by SARS-CoV-2 infection: An Italian prospective observational study.
    Stefanizzi P; Larocca AMV; Martinelli A; Soldano S; Dell'Aera M; Migliore G; Germinario CA; Vimercati L; Tafuri S; Bianchi FP
    Vaccine; 2022 Mar; 40(12):1805-1809. PubMed ID: 35190212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 antibody response after mRNA vaccination in healthcare workers with and without previous COVID-19, a follow-up study from a university hospital in Poland during 6 months 2021.
    Owsianka I; Pac A; Jachowicz E; Gutkowska K; Szczuciński W; Maziarz B; Sochacka-Tatara E; Heczko P; Sydor W; Żółtowska B; Wójkowska-Mach J
    Front Immunol; 2022; 13():1071204. PubMed ID: 36685606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic and Mucosal Humoral Immune Response Induced by Three Doses of the BNT162b2 SARS-CoV-2 mRNA Vaccines.
    Mancuso R; Agostini S; Citterio LA; Chiarini D; Santangelo MA; Clerici M
    Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia.
    Cucunawangsih C; Wijaya RS; Lugito NPH; Suriapranata I
    Int J Infect Dis; 2021 Dec; 113():15-17. PubMed ID: 34614445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up.
    Ponticelli D; Madotto F; Conti S; Antonazzo IC; Vitale A; Della Ragione G; Romano ML; Borrelli M; Schiavone B; Polosa R; Ferrara P; Mantovani LG
    Intern Emerg Med; 2022 Mar; 17(2):481-486. PubMed ID: 34637084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Previous SARS-CoV-2 Infection on Antibody Response to a Single Immunization with the Pfizer BNT162b mRNA Vaccine Among Healthcare Workers in Foggia, Italy.
    Homan T; Fortunato F; Corso G; Lopalco PL; Prato R; Martinelli D
    Infect Dis Ther; 2022 Feb; 11(1):607-615. PubMed ID: 34964938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eight-Month Follow-up After the Third Dose of BNT162b2 Vaccine in Healthcare Workers: The Question of a Fourth Dose.
    Lim SH; Choi SH; Kim JY; Kim B; Kim HJ; Kim SH; Kim CK; Park SK; Yun J
    J Korean Med Sci; 2023 May; 38(18):e139. PubMed ID: 37158775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance evaluation of an automatic chemiluminescence immune platform for SARS-CoV-2 neutralizing antibody after vaccination in real world.
    Li M; Jiang R; Wang E; Xiong D; Ou T; Zhang X; Dou X
    BMC Infect Dis; 2022 Feb; 22(1):157. PubMed ID: 35168557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum Antibody Response Comparison and Adverse Reaction Analysis in Healthcare Workers Vaccinated with the BNT162b2 or ChAdOx1 COVID-19 Vaccine.
    Lim SH; Choi SH; Kim B; Kim JY; Ji YS; Kim SH; Kim CK; Kim T; Choo EJ; Moon JE; Yun J; Park SK
    Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination.
    Bonura F; Genovese D; Amodio E; Calamusa G; Sanfilippo GL; Cacioppo F; Giammanco GM; De Grazia S; Ferraro D
    Vaccines (Basel); 2022 May; 10(6):. PubMed ID: 35746482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination Hesitancy among Health-Care-Workers in Academic Hospitals Is Associated with a 12-Fold Increase in the Risk of COVID-19 Infection: A Nine-Month Greek Cohort Study.
    Ntziora F; Kostaki EG; Grigoropoulos I; Karapanou A; Kliani I; Mylona M; Thomollari A; Tsiodras S; Zaoutis T; Paraskevis D; Sipsas NV; Antoniadou A; Sfikakis PP
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2).
    Favresse J; Bayart JL; Mullier F; Dogné JM; Closset M; Douxfils J
    Clin Microbiol Infect; 2021 Sep; 27(9):1351.e5-1351.e7. PubMed ID: 33975007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of SARS-CoV-2 Spike Antibodies after the Second and Third Dose of the BNT162b2 COVID-19 Vaccine and Association with Epidemiological Characteristics and Breakthrough Infection in a Cohort Study of Healthcare Workers.
    Tatsi EB; Filippatos F; Dellis C; Dourdouna MM; Syriopoulou V; Michos A
    Microorganisms; 2023 Aug; 11(8):. PubMed ID: 37630570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 Vaccination and Asymptomatic Infection: Effect of BNT162b2 mRNA Vaccine on the Incidence of COVID-19 and Duration of Sick Leave Among Healthcare Workers.
    Prato' S; Paladino ME; Riva MA; Belingheri M
    J Occup Environ Med; 2021 Dec; 63(12):e868-e870. PubMed ID: 34538839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.